about
Overcoming therapeutic resistance in glioblastoma: the way forwardRecent advances in subtyping tumors of the central nervous system using molecular data.Genomic and transcriptomic characterization of skull base chordoma.MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells.Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.Glioblastoma targeted therapy: updated approaches from recent biological insights.Glioma Subclassifications and Their Clinical Significance.Correlation of immune phenotype with IDH mutation in diffuse glioma.Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.Spatiotemporal genomic architecture informs precision oncology in glioblastoma.FGFR-TACC gene fusions in human glioma.Evolutionary scalpels for dissecting tumor ecosystems.Scaling single-cell genomics from phenomenology to mechanism.The evolution of tumour phylogenetics: principles and practice.A population genetics perspective on the determinants of intra-tumor heterogeneity.Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma.Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint.Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli.A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.Classifying the evolutionary and ecological features of neoplasms.Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology.Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio.Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastomas.TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol.Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment.SHP2 regulates proliferation and tumorigenicity of glioma stem cells.EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
P2860
Q29248396-4C2E2564-4488-47BD-8BE7-4BD51DC3109AQ31145092-69DB87FD-4EA3-4322-AE1F-C217248C24B0Q33276293-D40708DD-D52F-4CD5-94FC-B61BA0583539Q37666955-68EEE572-5434-484B-BF5C-829EBB43E4D4Q38400073-D6DBF9EB-21C3-4CF8-A061-041B8735F7CAQ38597700-8B50F8EF-1A04-4276-8E8B-D297EF248BF4Q38747746-146D6FEA-FBC7-4BB5-8E8A-29B1E267E414Q38771020-5C212EFA-2C84-4F57-8AC6-4E03A53B9C12Q38838354-BFB3AB32-C787-4482-920F-DE849EB02F02Q38858481-9CE9B67D-B728-4B3B-9639-DBE27B93F7C4Q38927317-A45A8AF4-9207-4FA3-837B-5434B95F482FQ39010445-E7A8C698-D882-454A-8977-9962A7A28BA4Q39030938-D6D5FC83-5B8B-4F36-88DD-4D4335800965Q39094767-095E0F88-39C6-493C-B3CC-A1AA749E2A79Q39132571-991EEA99-1519-443A-9FD4-0AB97EFF3045Q39169154-2C267CD5-A037-45C3-A4F6-12BC337E58CAQ39243060-B0CBD256-D02E-48C6-B83C-A3F4946EB474Q39354541-3D158A1A-5B69-4C06-B6CA-D84E4244040FQ39377159-A87B667D-B31E-47A8-94B7-068A19E7D8D1Q39475779-5C401D93-DC56-47B6-AB79-F2D81140515CQ40116157-754F0CDF-1780-4852-B37A-3EA525DFA204Q40230898-7CA3D56E-FA38-4AC6-892D-D3EC1704D9BFQ41920857-23C504CD-E014-439D-9779-43E7152CE073Q42689844-C3489B19-4F8A-4382-AC8F-CE305510A2FDQ43056671-18C75F95-768E-4EBD-BC15-AD2976CA3DD4Q44411444-09256050-0C53-424E-82F3-44AF980287A8Q45067426-B2CFDE81-4A86-48F8-8341-961338C715D4Q45070125-9A32F625-94C6-4034-B664-78AB434638D0Q45951581-7DC58021-9BD5-4983-9DDE-9C6B2DFA290EQ46410971-E8D40A72-25C3-4EE7-BD4F-C6344FC1C2B6Q47161729-520968FA-9C75-474B-B0B0-4969B0F0C9A4Q47239499-E56BE528-5420-4032-B243-E6F6759A6BEAQ47304287-B65DFCEA-5D92-44B4-BB7A-C9356E8A55D7Q47329655-E9C688B4-64ED-4D23-B63D-2D457121AC2AQ47558605-0D01852B-732E-4747-9059-8AF55FA99355Q47770490-1B1C63E1-C7EC-4565-AF63-40AE019C583FQ47827527-6CAA7F04-1F66-44DF-ACCC-1D0CC4B381A6Q47875411-B2B58254-EDC6-4E1E-BB6A-096E6F7E608CQ47885098-92A3878B-44A3-4C9D-ABEB-E94ECDF65963Q48014727-73B4DAC1-7F2A-4113-A61B-EB6322ECF61D
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clonal evolution of glioblastoma under therapy.
@en
Clonal evolution of glioblastoma under therapy.
@nl
type
label
Clonal evolution of glioblastoma under therapy.
@en
Clonal evolution of glioblastoma under therapy.
@nl
prefLabel
Clonal evolution of glioblastoma under therapy.
@en
Clonal evolution of glioblastoma under therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clonal evolution of glioblastoma under therapy
@en
P2093
Andrew J Blumberg
Do-Hyun Nam
Emanuela Cazzato
Erik Ladewig
Francesco Abate
Gaetano Finocchiaro
In-Hee Lee
Jin-Ku Lee
Oliver Elliott
Sakellarios Zairis
P2860
P2888
P304
P356
10.1038/NG.3590
P407
P577
2016-06-06T00:00:00Z